Randomized Study of Aspirin Resistant Patients Undergoing Angioplasty

NCT00289601 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

1200

Enrollment

OTHER

Sponsor class

Stopped Sponsor support withdrawn

Conditions

Angioplasty

Interventions

DRUG: eptifibatide

Sponsor

Brigham and Women's Hospital

Collaborators

[object Object]